Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
about
Personalized medicine in rheumatologySpondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Recent advances of exosomes in immune modulation and autoimmune diseases.Case Report: Elevated CPK, an indicator of idiopathic inflammatory myopathy?S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.Proteomics for Allergy: from Proteins to the Patients.Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.Translating epigenetics into clinic: focus on lupus.Genome-wide DNA methylation analysis in blood cells from patients with Werner syndromeOsteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE.Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis.Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.Coagulation cascade and complement system in systemic lupus erythematosus.
P2860
Q28077413-E8E0C0F3-7872-46B7-ADF5-1957D5A092EAQ33624763-2CE0CA55-B58F-4234-8CA3-A82A882B411AQ36040260-226424D7-2321-4333-AABB-D51597BC24B3Q37137104-F1A3B749-2C01-4661-ABBE-83C6796A3C84Q37364345-8669CC4F-9E59-41D1-8351-94B80E354F61Q38825869-BFB1F83B-9AE2-4FC9-BD50-D3F144B73C29Q38851096-35379791-8D50-4251-B9FC-DB6B5B3F2A72Q38930142-BF2514BA-462B-4828-BEE8-0F2320EA8746Q40381133-C8376CA0-BEF8-46A7-BF1E-2AB9029D1BB9Q41228881-F6803846-E547-41F4-BAF4-8D77F099C8BDQ41571756-43FAB4A2-B51A-44F5-A8F4-5C883189618BQ47130347-94C6DC79-1AFD-4875-AC20-998234462129Q47165308-CA3CD8FC-C33A-470B-A27A-4A39EF22031AQ48508515-6B5B900F-F599-40E9-BE8A-57BEEA5B279CQ52620432-4D1B4DB4-6096-4729-A12B-D2D96235A6CB
P2860
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@ast
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@en
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@nl
type
label
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@ast
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@en
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@nl
prefLabel
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@ast
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@en
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@nl
P3181
P356
P1433
P1476
Biomarkers in rheumatic diseas ...... ssessment of disease activity?
@en
P2093
Chandra Mohan
Shervin Assassi
P3181
P356
10.1136/BMJ.H5079
P407
P577
2015-01-01T00:00:00Z